Rethinking Cancer Targeting Strategies in the Era of Smart Cell Therapeutics

Althought emerging smart cell engineering capabilities have yet to be fully implemented in the clinic, investigators argue here that they will become much more powerful when combined with machine learning analysis of genomic data.